华盛顿州立大学在人类临床试验中进行的20mg-hemp派生的CBG大大降低了焦虑和压力。 20mg hemp-derived CBG significantly reduced anxiety and stress in a human clinical trial conducted by Washington State University.

科学报告中最近的一项研究发现,Cannabigerol(CBG)是一种不太为人所知的大麻素,它大大减少了没有中毒的焦虑,通常与整个大麻植物有关。 A recent study in Scientific Reports found that Cannabigerol (CBG), a lesser-known cannabinoid, significantly reduces anxiety without intoxication, typically associated with whole plant cannabis. 华盛顿州立大学进行的人类临床试验涉及34名健康的大麻使用者,他们与安慰剂相比,摄入了20毫克从大麻中得来的氯丙烷后,焦虑和紧张程度有所下降。 The human clinical trial conducted by Washington State University involved 34 healthy cannabis users who experienced reduced anxiety and stress levels after ingesting 20mg of hemp-derived CBG compared to a placebo. CBG还展示了潜在的促进记忆效应,与会者在服用该物质后回顾更多的词句。 CBG also showed potential memory-enhancing effects, with participants recalling more words after taking the substance. 研究结果可能会为减少焦虑和压力开辟新的途径,而不会产生有毒化学品和有毒化学品中毒的影响。 The study's findings may open new avenues for reducing anxiety and stress without the intoxicating effects of THC.